Title
The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
Phase
Phase 4Lead Sponsor
Public Health EnglandStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Haemophilus Influenzae Type bIntervention/Treatment
haemophilus influenzae type b conjugate vaccine ...Study Participants
NoneTo measure the magnitude and persistence of the antibody response to a booster dose of Hib conjugate vaccine given between 9 months and 4 years of age to UK children who had completed primary immunisation with 3 doses of Hib vaccine given at 2/3/4 months of age either as a combined D/T/wholecellpertussis/Hib or D/T/acellularpertussis/Hib vaccine.
Inclusion Criteria: Written informed consent from parent or legal guardian of the infant or child Age >= 9 months and <4 years at recruitment Eligible to receive a single dose of Hib vaccine as per the UK schedule Receipt of three doses of Hib vaccine in infancy Exclusion Criteria: History of Hib infection History of severe local reaction that can be confidently related to a prior Hib immunisation Deferral of vaccination if acute illness and/or temperature >38C on day of vaccination